Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMBAT-19: Mavrilimumab for COVID-19 Pneumonia
NCT04397497Phase 2Unknown
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- May 2020
- Primary completion
- Sep 2020
- Countries
- 1
01
Overview
A Phase 2 trial of mavrilimumab in COVID-19 pneumonia, acute respiratory failure (ARF), sponsored by IRCCS Ospedale San Raffaele. Status: unknown.
02
Drugs
mavrilimumab
03
Conditions
COVID-19 pneumoniaacute respiratory failure (ARF)
Beyond the preview
Go deeper on NCT04397497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04397497.